Position statement of the EADV Melanoma Task Force on recommendations for the management of cutaneous melanoma patients during COVID-19.

Abstract

Journal of the European Academy of Dermatology and VenereologyVolume 35, Issue 7 p. e427-e428 Letter to the Editor Position statement of the EADV Melanoma Task Force on recommendations for the management of cutaneous melanoma patients during COVID-19 M. Arenbergerova, Corresponding Author M. Arenbergerova [email protected] Department of Dermatovenereology, Third Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital, Prague, Czech Republic Correspondence: M. Arenbergerova. E-mail: [email protected].Search for more papers by this authorA. Lallas, A. Lallas orcid.org/0000-0002-7193-0964 First Department of Dermatology, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, GreeceSearch for more papers by this authorE. Nagore, E. Nagore orcid.org/0000-0003-3433-8707 Department of Dermatology, Instituto Valenciano de Oncología, Valencia, Spain School of Medicine, Universidad Católica de Valencia San Vicente Mártir, Valencia, SpainSearch for more papers by this authorL. Rudnicka, L. Rudnicka orcid.org/0000-0002-8308-1023 Department of Dermatology, Medical University of Warsaw, Warsaw, PolandSearch for more papers by this authorA.M Forsea, A.M Forsea orcid.org/0000-0002-1007-7883 Carol Davila University of Medicine and Pharmacy Bucharest, Bucharest, Romania Oncologic Dermatology Department, Elias University Hospital Bucharest, Bucharest, RomaniaSearch for more papers by this authorM. Pasek, M. Pasek Department of Dermatovenereology, Third Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital, Prague, Czech RepublicSearch for more papers by this authorF. Meier, F. Meier Skin Cancer Center at the University Cancer Centre Dresden and National Center for Tumor Diseases, Dresden, Germany Department of Dermatology, University Hospital Carl Gustav Carus, TU Dresden, Dresden, GermanySearch for more papers by this authorK. Peris, K. Peris orcid.org/0000-0003-1957-6600 UOC di Dermatologia, Università Cattolica del Sacro Cuore, Rome, Italy Dermatologia Fondazione Policlinico Universitario A. Gemelli – IRCCS, Rome, ItalySearch for more papers by this authorJ. Olah, J. Olah Department of Oncotherapy, Department of Dermatology and Allergology, University of Szeged, Szeged, HungarySearch for more papers by this authorC. Posch, C. Posch orcid.org/0000-0003-0296-3567 Department of Dermatology and Allergy, School of Medicine, German Cancer Consortium (DKTK), Technical University of Munich, Munich, Germany Faculty of Medicine, Sigmund Freud University Vienna, Vienna, AustriaSearch for more papers by this author M. Arenbergerova, Corresponding Author M. Arenbergerova [email protected] Department of Dermatovenereology, Third Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital, Prague, Czech Republic Correspondence: M. Arenbergerova. E-mail: [email protected].Search for more papers by this authorA. Lallas, A. Lallas orcid.org/0000-0002-7193-0964 First Department of Dermatology, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, GreeceSearch for more papers by this authorE. Nagore, E. Nagore orcid.org/0000-0003-3433-8707 Department of Dermatology, Instituto Valenciano de Oncología, Valencia, Spain School of Medicine, Universidad Católica de Valencia San Vicente Mártir, Valencia, SpainSearch for more papers by this authorL. Rudnicka, L. Rudnicka orcid.org/0000-0002-8308-1023 Department of Dermatology, Medical University of Warsaw, Warsaw, PolandSearch for more papers by this authorA.M Forsea, A.M Forsea orcid.org/0000-0002-1007-7883 Carol Davila University of Medicine and Pharmacy Bucharest, Bucharest, Romania Oncologic Dermatology Department, Elias University Hospital Bucharest, Bucharest, RomaniaSearch for more papers by this authorM. Pasek, M. Pasek Department of Dermatovenereology, Third Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital, Prague, Czech RepublicSearch for more papers by this authorF. Meier, F. Meier Skin Cancer Center at the University Cancer Centre Dresden and National Center for Tumor Diseases, Dresden, Germany Department of Dermatology, University Hospital Carl Gustav Carus, TU Dresden, Dresden, GermanySearch for more papers by this authorK. Peris, K. Peris orcid.org/0000-0003-1957-6600 UOC di Dermatologia, Università Cattolica del Sacro Cuore, Rome, Italy Dermatologia Fondazione Policlinico Universitario A. Gemelli – IRCCS, Rome, ItalySearch for more papers by this authorJ. Olah, J. Olah Department of Oncotherapy, Department of Dermatology and Allergology, University of Szeged, Szeged, HungarySearch for more papers by this authorC. Posch, C. Posch orcid.org/0000-0003-0296-3567 Department of Dermatology and Allergy, School of Medicine, German Cancer Consortium (DKTK), Technical University of Munich, Munich, Germany Faculty of Medicine, Sigmund Freud University Vienna, Vienna, AustriaSearch for more papers by this author First published: 29 March 2021 https://doi.org/10.1111/jdv.17252Citations: 7Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article.Citing Literature Volume35, Issue7July 2021Pages e427-e428 This article also appears in:JEADV COVID-19 articles RelatedInformation